Bone Marrow CD133+ Stem/Progenitor Cells, Frozen

Bone marrow mononuclear cells (MNCs) are separated from whole bone marrow by a density gradient centrifugation protocol. CD133+ stem and progenitor cells are positively selected using immunomagnetic anti-CD133 (clone AC133) microbeads from the MNC population. CD133+ cells characterized by flow cytometry before cryopreservation to ensure a highly pure and viable cell population.

Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies.  By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.

CGT Global - Landing Page Desktop Prototype

Description

Human CD133 is a transmembrane glycoprotein that is expressed on CD34+ and CD34- multipotent stem and progenitor cells that are involved in hematopoiesis. Unlike CD34+ cells, bone marrow CD133+ cells are involved in vasculogenesis giving rise to endothelial cell precursors. Additionally, bone marrow CD133+ hematopoietic cells have been found to differentiate in vitro to cells of the ectodermal and mesodermal lineages implying that these cells have the ability to give rise to cells of non-hematopoietic lineages.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Additional information

Anticoagulant

Format

Grade

Species

Cell and Tissue Source

Disease State

Donor Attributes

Product Information Sheet

BM CD133 – Frozen

Material Safety Data Sheet

Bone Marrow – Frozen

 

Used in Research

Selected publications demonstrating the use of human bone marrow and bone marrow–derived cells sourced from StemExpress in regenerative medicine, stem cell, and immunology research.


Identification of osteogenic progenitor cell-targeted peptides that augment bone formation

Nature Communications · 2020

Bone marrow aspirates were used to study osteogenic progenitor cell targeting and bone formation mechanisms.

“Bone marrow aspirates were obtained from healthy human donors (StemExpress…)”

Bone Marrow · Regenerative Medicine


Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells

Annals of Translational Medicine · 2021

Bone marrow-derived CD34+ stem cells were used to evaluate regenerative therapies in retinal degeneration models.

“Fresh bone marrow from a healthy human donor was obtained from StemExpress…”

CD34+ Cells · Stem Cell Therapy


Effects of intravitreal injection of human CD34+ bone marrow stem cells

Experimental Eye Research · 2020

Bone marrow-derived CD34+ stem cells were used to investigate therapeutic effects in retinal disease models.

Stem Cells · Ophthalmology


Human mesenchymal stem cells suppress proliferation of activated lymphocytes

Cellular Immunology · 2016

Bone marrow-derived mesenchymal stem cells were used to evaluate immune suppression and regulatory T cell responses.

“Bone marrow-derived MSCs… were purchased from StemExpress (Placerville, CA)”

MSC · Immunology


Proteomic analysis of exosomes secreted from mesenchymal stromal cells

Biology · 2021

Bone marrow-derived mesenchymal stromal cells were used to study exosome secretion and cellular communication.

“Bone marrow specimens… purchased from StemExpress…”

MSC · Exosomes